Washington, D.C. (December 22, 2015) – Uniting for Health Innovation’s Technical Advisory Group (FTAG) and Board of Trustees met in Washington D.C. December 3-4 2015, to review 2015 accomplishments and adopt the plan and budget for 2016.
The Board of Trustees also recognized the service of two out-going members Harold Hamana, Director, Knight & Pawn and David Aiken, Principal (Partner), VentureCount, LLC and welcomed new Trustees Mark Moore, Co-Founder, Mark and Brenda Moore Family Foundation and Joel Dziengielewski, Director, Navigant.
Uniting for Health Innovation and PAHO Bestow the Manuel Velasco-Suárez Award to Róderic Molins Mota of Puerto Rico
Mexico City, Mexico (November 19, 2015) – Uniting for Health Innovation and the Pan America Health Organization today presented Róderic Molins Mota, of the University of Puerto Rico, with the 2015 Manuel Velasco-Suárez Award for her noteworthy research proposal “Justice and Equity in the Distribution of Health Resources.”
In the past, Molins worked on initiatives concerning ethics in the allocation of health resources. Her efforts to improve Puerto Rico’s health care system inspired her research proposal that won this year’s Velasco-Suárez award.
Washington, D.C. (November 13, 2015) – Uniting for Health Innovation announced a two-year grant to the Pan American Health Organization to help Peru extend health care services in the Cajamarca region to some 573,888 Peruvians and improve over 100 health networks.
Reducing high maternal mortality rates in the low-income rural areas, such as the provinces of Cajamarca and Jaen in Peru, is a major goal of the Pan American Health Organization's region-wide program to improve women’s health. The program addresses women’s health needs across the life course and improves the quality and sustainability of the health infrastructure in poor communities.
Recently, we had the pleasure of catching up with Dr. Ignacio Damián Mastroleo, the Pan American Health Organization/Uniting for Health Innovation 2014 winner of the Manuel Velsaco-Suárez Award for Excellence in Bioethics, on his research and activities since the award ceremony last fall in Washington DC.
Read our Q&A with Dr. Mastroleo below!
Uniting for Health Innovation: What have been your research areas over the past year since being awarded the Manuel Velasco-Suárez Award for Excellence in Bioethics?
September 28, 2015 – Uniting for Health Innovation’s Technical Advisory Group (FTAG) met last Friday (September 25, 2015) to establish first year and long-term goals, discuss upcoming initiatives, prioritize health issues and craft impending meeting agendas.
The meeting opened up with greetings and introductions from interim co-chairs, Drs. Tim Ford and Rita Colwell, followed by a message from Uniting for Health Innovation President and CEO, Dr. Jennie Ward-Robinson, outlining the Foundation’s progressions and future aspirations.
September 16, 2015 – Mexico has eliminated river blindness and joins Colombia and Ecuador as endemic countries in Latin America to have achieved the World Health Organization’s (WHO) criteria for being declared free of river blindness.
Over the past decade, Uniting for Health Innovation partnered with Merck and others to provide some eight million treatments of Mectizan tablets annually for more than 400,000 people in the Americas to support mass campaigns for the elimination of river blindness.
WASHINGTON, D.C. (August 17, 2015) – Uniting for Health Innovation has appointed Mark Moore, Co-Founder of the Mark and Brenda Moore Family Foundation, to its Board of Trustees for a three year term.
“The Uniting for Health Innovation Board of Trustees is thrilled to welcome Mr. Moore as our newest Trustee. Countries of Latin American and the Caribbean and Uniting for Health Innovation will benefit immensely from his generosity and leadership,” Dr. Jennie Ward-Robinson, Uniting for Health Innovation President and CEO, said.
WASHINGTON, D.C. (August 17,2015) – Uniting for Health Innovation has appointed Veronica Muzquiz Edwards, InGenesis President and CEO, Vice Chair of the Board of Trustees and member of the Executive Committee for a one year term effective June 5, 2015.
“The Uniting for Health Innovation Board of Trustees is pleased to welcome Ms. Edwards to this leadership role. Countries of Latin America and the Caribbean as well as Uniting for Health Innovation will benefit immensely from her commitment to public health, her business acumen and community engagement,” Dr. Jennie Ward-Robinson, Uniting for Health Innovation President and CEO, said.
July 2, 2015 – Uniting for Health Innovation congratulates Cuba for being the first country to end mother-to-infant transmission of syphilis and HIV.
WHO has set up specific criteria to determine whether countries can be considered free of mother-to-child transmission of HIV and syphilis. Elimination of infectious diseases is defined as having infection rates low enough that they no longer pose significant harm to the public. Thanks to Cuba’s partnership with the Pan American Health Organization/WHO, the country has employed successful regional initiatives to end mother-to-child transmission of the diseases.
May 8, 2015 – Uniting for Health Innovation joins the Pan American Health Organization, its member countries, and partners in celebrating the historic declaration of the elimination of rubella in the Americas. The declaration of elimination, made by an international expert committee during a meeting at the Pan American Health Organization/World Health Organization (WHO) last week, makes rubella and congenital rubella syndrome (CRS) the third and fourth vaccine-preventable diseases to be eliminated from the Americas, following the regional eradication of smallpox in 1971 and the elimination of polio in 1994.